Advocating for an improved patent applications process in Ukraine
The decision to grant or refuse a patent has an impact on the price of essential medicines – and huge...
All-Ukrainian Network of PLHIV continues to struggle for affordable LPV/r
Network of people living with HIV submits second opposition to patent on essential HIV drug in Ukraine On 30 January...
Patent on HIV and Hepatitis drug TAF challenged in Ukraine
On 28 December 2016, the All-Ukrainian Network of People Living with HIV/AIDS submitted a patent invalidation claim against Gilead patent...
Debating patent law and access to medicines in Ukraine
Last month (9 December 2016), the All-Ukrainian Network of People Living with HIV/AIDS held a roundtable meeting on ‘Patent Law...
Price of HIV Drug Atripla Set to Drop
Almost 3000 more people living with HIV set to get life-saving treatment in Ukraine.
Civil Society Advocates for Intellectual Property Law Reform in Ukraine
The All-Ukrainian Network of People Living with HIV (Network) advocate for change of law to improve access to medicines, in...
Compulsory licensing to increase access to antiretroviral drugs
The Network organizes Roundable to explore Compulsory Licensing for Ukraine On 22 June 2016, the All-Ukrainian Network of People Living...
High price of lopinavir/ritonavir challenged in Ukraine
All-Ukrainian PLHIV Network challenges patent, and exclusive right to manufacture lopinavir/ritonavir.
How to reach 90-90-90 in Ukraine
Today, 3 December 2015, the All-Ukrainian Network of People Living with HIV (the Network) hosted a roundtable meeting to explore...
Opportunities to Overcome Patent Barriers in Ukraine
The All-Ukrainian Network of People Living with HIV brought together representatives from Indian and Ukrainian generic drug manufacturers to discuss...